mdm2 mRNA Level is a Prognostic Factor in Soft Tissue Sarcoma

被引:0
|
作者
Helge Taubert
Thomas Koehler
Axel Meye
Frank Bartel
Christiane Lautenschläger
Silke Borchert
Matthias Bache
Hannelore Schmidt
Peter Würl
机构
[1] Martin-Luther-University of Halle-Wittenberg,Institute of Pathology
[2] Martin-Luther-University of Halle-Wittenberg,Institute of Medical Biometry and Informatics
[3] Martin-Luther-University of Halle-Wittenberg,Department of Radiotherapy
[4] University of Leipzig,Department of Clinical Chemistry and Pathobiochemistry, Division of Molecular Biology
[5] University of Leipzig,Clinic of Surgery 1
来源
Molecular Medicine | 2000年 / 6卷
关键词
Mdm2 mRNA Expression; Soft Tissue Sarcomas (STS); Gene Therapeutic Approaches; MDM2 Protein; Integrated Separation Systems;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:50 / 59
页数:9
相关论文
共 50 条
  • [31] Expression of MDM2 Protein and mRNA in Condyloma Acuminata
    朱里
    涂亚庭
    黄长征
    刘厚君
    冯爱平
    Current Medical Science, 2004, (05) : 493 - 496
  • [32] Targeting MDM2 in Soft-Tissue Sarcomas (and Other Solid Tumors): The Revival?
    Italiano, Antoine
    CANCER DISCOVERY, 2023, 13 (08) : 1765 - 1767
  • [33] Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients
    Hahnel, Antje
    Wichmann, Henri
    Greither, Thomas
    Kappler, Matthias
    Wuerl, Peter
    Kotzsch, Matthias
    Taubert, Helge
    Vordermark, Dirk
    Bache, Matthias
    BMC CANCER, 2012, 12
  • [34] Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients
    Antje Hahnel
    Henri Wichmann
    Thomas Greither
    Matthias Kappler
    Peter Würl
    Matthias Kotzsch
    Helge Taubert
    Dirk Vordermark
    Matthias Bache
    BMC Cancer, 12
  • [35] Expression of MDM2 protein and mRNA in condyloma acuminata
    Zhu Li
    Tu Yating
    Huang Changzheng
    Liu Houjun
    Feng Aiping
    Current Medical Science, 2004, 24 (5) : 493 - 496
  • [36] Prognostic significance of nuclear accumulation of c-myc and mdm2 proteins in synovial sarcoma of the extremities
    Shen, JN
    Scotlandi, K
    Baldini, N
    Manara, MC
    Benini, S
    Cerisano, V
    Picci, P
    Serra, M
    ONCOLOGY, 2000, 58 (03) : 253 - 260
  • [37] Histopathologic type: An independent prognostic factor in primary soft tissue sarcoma of the extremity?
    Koea, JB
    Leung, D
    Lewis, JJ
    Brennan, MF
    ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (04) : 432 - 440
  • [38] p53 mutations as prognostic factor for soft tissue sarcoma patients
    Taubert, H
    Meye, A
    Bache, M
    Kroll, J
    Holzhausen, HJ
    Hinze, R
    Schmidt, H
    Rath, FW
    EUROPEAN JOURNAL OF CELL BIOLOGY, 1997, 72 : 331 - 331
  • [39] Histopathologic Type: An Independent Prognostic Factor in Primary Soft Tissue Sarcoma of the Extremity?
    Jonathan B. Koea
    Dennis Leung
    Jonathan J. Lewis
    Murray F. Brennan
    Annals of Surgical Oncology, 2003, 10 : 432 - 440
  • [40] A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas
    Rieske, P
    Bartkowiak, JK
    Szadowska, AM
    Olborski, B
    Harezga-Bal, B
    Debiec-Rychter, M
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1999, 18 (03): : 403 - 416